Multi-Modality Treatment in Basal Cell Carcinoma

1 Views
administrator
administrator
07/14/23

Panelists Keith T. Flaherty, MD; Jonathan S. Zager, MD; Georgina Long, BSc, MBBS; Jason J. Luke, MD; and Jeffrey S. Weber, MD; discuss how hedgehog pathway inhibitors change how patients with advanced basal cell carcinoma are treated and provide thoughts on the future of melanoma.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next